Fosun Pharma's subsidiary, Fosun Pharma Industrial, has entered a licence agreement to grant ex-China rights for its experimental respiratory drug, XH-S004, to Expedition Therapeutics. This agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results